A Critical Review on Chagas Disease Chemotherapy
Top Cited Papers
Open Access
- 1 January 2002
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 97 (1) , 3-24
- https://doi.org/10.1590/s0074-02762002000100001
Abstract
In this "Critical Review" we made a historical introduction of drugs assayed against Chagas disease beginning in 1912 with the works of Mayer and Rocha Lima up to the experimental use of nitrofurazone. In the beginning of the 70s, nifurtimox and benznidazole were introduced for clinical treatment, but results showed a great variability and there is still a controversy about their use for chronic cases. After the introduction of these nitroheterocycles only a few compounds were assayed in chagasic patients. The great advances in vector control in the South Cone countries, and the demonstration of parasite in chronic patients indicated the urgency to discuss the etiologic treatment during this phase, reinforcing the need to find drugs with more efficacy and less toxicity. We also review potential targets in the parasite and present a survey about new classes of synthetic and natural compounds studied after 1992/1993, with which we intend to give to the reader a general view about experimental studies in the area of the chemotherapy of Chagas disease, complementing the previous papers of Brener (1979) and De Castro (1993).Keywords
This publication has 166 references indexed in Scilit:
- 2- and 3-Substituted 1,4-Naphthoquinone Derivatives as Subversive Substrates of Trypanothione Reductase and Lipoamide Dehydrogenase from Trypanosoma cruzi: Synthesis and Correlation between Redox Cycling Activities and in Vitro CytotoxicityJournal of Medicinal Chemistry, 2001
- Evaluation of the Trypanocidal Activity of Lignans Isolated from the Leaves of Zanthoxylum naranjilloPlanta Medica, 1999
- Reactivation of Chagas' Disease in Patients with AIDS: Report of Three New Cases and Review of the LiteratureClinical Infectious Diseases, 1997
- Etiological treatment for chagas disease—The National Health Foundation of BrazilParasitology Today, 1997
- Chelating agent inhibition of Trypanosoma cruzi epimastigotes In vitroJournal of Inorganic Biochemistry, 1995
- Inhibition of cruzipain, the major cysteine proteinase of the protozoan parasite, Trypanosoma cruzi, by proteinase inhibitors of the cystatin superfamilyFEBS Letters, 1995
- Chagas' disease: carcinogenic activity of the antitrypanosomal nitroarenes in miceMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1994
- A rationale for antiparasite drug discoveryParasitology Today, 1994
- Effect of gangliosides on trypanosoma cruzi infection in miceLife Sciences, 1993
- Interaction of benznidazole reactive metabolites with nuclear and kinetoplastic DNA, proteins and lipids fromTrypanosoma cruziCellular and Molecular Life Sciences, 1988